Start Date
End Date
Event Speciality
Event Cost:
500
£
Event Capacity
500
For registration/tickets purchase:
https://www.virtueinsight.com/pharma/4th-Pharma-Pricing-Reimbursement--Market-Access-2021-Virtual-Conference/
Session brief description
4th Pharma Pricing, Reimbursement & Market Access 2021 (Virtual Conference) 2021
Session Start Date
Session End Date
Abstract Submission Deadline
Abstract guidelines

This conference will provide an overview of global pricing, market access systems and cost management techniques, as well as in-depth discussion of some of the most current trends and changes. This Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. It will be studied with the help of case studies and industry experiences.

4th Pharma Pricing, Reimbursement & Market Access 2021 (Virtual Conference) 2021

4th Annual Pharma Pricing, Reimbursement & Market Access 2021

29th - 30th June 2021, Virtual Conference (Time Zone - BST)

This conference will provide an overview of global pricing, market access systems and cost management techniques, as well as in-depth discussion of some of the most current trends and changes. This Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. It will be studied with the help of case studies and industry experiences. Following a raft of health policy reforms impacting pharmaceutical pricing in almost every major country in the EU, it gives me great pleasure in welcoming all of you to the Virtue Insight’s 3rd Annual Pharma Pricing, Reimbursement & Market Access 2020.  I wish and pray that all our efforts will be beneficial to our industry and to our country at large.

DELEGATE REGISTRATION:

Email: kavitha@virtueinsight.co.in  or Call: +44-20 3509 3779

Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer.

EARLY BIRD PRICE

1 Delegate @ £300 +VAT (Valid Till 24th May 2021)

3 Delegates @ £700 +VAT (Valid Till 24th May 2021)

STANDARD PRICE

1 Delegate @ £500 +VAT (Valid From 25th May 2021)

3 Delegates @ £1200 +VAT (Valid From 25th May 2021)

Conference Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest and queries to kavitha@virtueinsight.co.in

KEY SPEAKERS:

  • GERGANA ZLATEVA, Vice President and Business Unit Lead, Oncology, Patient & Health Impact, Pfizer
  • VIVECA PARKER, Assistant US Attorney, Dept of Justice
  • ADAM LEVYSOHN, Head of Biogen Value & Access Alzheimer’s Disease, Biogen
  • MARIA ALEJANDRA BLANC, Director - Regulatory Affairs, Abbvie
  • MARIO OUWENS, Senior Statistical Science Director, Group director Medical & Payer Evidence Statistics, AstraZeneca
  • LAURENE REDDING, Head, Value, Access & Policy, BeiGene
  • LARA PIPPO, Head of Market Access & Government Affairs, CSL Behring
  • SAMUEL MURPHY, VP & Head of International BD, Shenzhen Salubris Pharmaceuticals
  • VIJAY REDDY, Senior Director - Global Market Access Strategy, Biocon Biologics
  • ALEEN HOSDAGHIAN, Brand Lead, US Immunology, UCB Pharma
  • JESPER BJERGGREN, European Market Access Lead, Digital Health, Teva Pharmaceuticals
  • OMAR ALI, Pharmacist Consultant, QIPP Adviser Payer Network
  • SARAH GARNER, Acting Program Manager - Access to Medicines and Health Products, WHO
  • MARCO MARCHETTI, Director, National Center for HTA, Istituto Superiore di Sanità
  • MARTIN SCHUCHARDT, Global Market Access & Pricing Lead, Almirall
  • NURIYA MUSINA, Head of Development, Center of Healthcare Quality Assessment and Control, Ministry of Health of The RF
  • ROBERT POPOVIAN, CEO, Former VP, Gov Relations, Conquest Advisors, Pfizer
  • LUC BOILEAU, President - Director General, INESSS
  • ISABELLE GANACHE, Director, INESSS
  • OLIVER LEATHAM, VP, Global Head of Commercial Strategy and EU Value & Access, Certara
  • MARTIJN NEGEN, VP Commercial Strategy, AM Pharma
  • IGOR RUDYCHEV, Vice President, Enterprise Analytics, Horizon Therapeutics
  • ROSEMARY JOSE, Senior Director, Strategic Market Access, Open Health
  • JUAN VERGEZ, Head of Marketing & Corporate Communications, Arvelle Therapeutics
  • ERIN MISTRY, SVP Payer Strategy, Government Affairs and Trade, Cormedix
  • REED STEPHENS, Partner, Winston & Strawn
  • TIM EPPLE, Principal, Financial Services, Avalere Health
  • ALEXANDER NATZ, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
  • MICHAEL THOMPSON, President & CEO, National Alliance of Healthcare Purchaser Coalition
  • SANDY EISEN, Chief Medical Officer, Frontline Pharma Consulting Ltd

Plus more joining soon

KEY THEMES DISCUSSED IN THIS CONFERENCE:

  • Preparing your best market access strategy
  • EU and US policy challenges for market access: Stepping ahead
  • Unrivalled opportunity to expose and address the market access challenges facing the industry
  • Current & future - Challenges & opportunities in pharma pricing, reimbursement & market access
  • Improving patient and market access through the development of targeted value propositions, comprehensive contract assessment
  • Measurement strategies through to in-depth knowledge regarding payer formulary coverage trends
  • How can payers and industry work together to ensure that innovative and valuable treatments make it to the market?
  • Understanding - payers’ perspective
  • Advocating and collaborating with payers for value in a new era
  • Creating a robust patient services and reimbursement support program for biosimilar products
  • Prioritising Patients! - Adding value through an innovative patient-centered approach
  • Understand how price affects market access and learn on how to set prices for optimal access and returns.
  • New drugs are failing to gain reimbursement from payers/HTAs at an alarming rate, despite being approved by regulators
  • Evidence Generation - The strategic rigor and creativity applied to evidence generation
  • Impact of social media and digital analytics
  • Developing risk-sharing reimbursement models and value based pricing
  • Patient engagement and adherence within the environment
  • Explaining how to use the data sources and observational research for effective safety analysis
  • Dwell ahead of regulatory developments & improving your strategies in a cost effective way in EU, US
  • Accelerating new medicine introduction in developing world & overcoming challenges
  • Be part of a major networking opportunity

WHO SHOULD ATTEND:

Senior Vice Presidents, Vice Presidents, Senior Executives, Global Heads, Heads, Directors, Senior Managers, Managers of:

Pricing, Reimbursement, Market Access, Commercial Pricing, Pricing Strategists, Health Economics, Outcomes Research, Regulatory Affairs, Governmental Affairs, Public Affairs, Public Policy Directors, Operations, Governmental bodies, Regulatory bodies

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the virtual exhibition area. Expand your knowledge of the latest business models and strategies in the high-level conference.

 

                                                                                                                    

Contact Organizer

Please login/register to communicate with the organizers of this event.

(1+) 206-575-7771
World Medical Events Company
12922 SE 299th Street, Auburn WA 98092 USA